Literature DB >> 7865378

Myositis and malignancy.

J P Callen1.   

Abstract

Dermatomyositis appears to be associated with a greater frequency of malignancy than expected in the general population. For polymyositis, there does not appear to be a greatly increased risk of malignancy. Ovarian cancer may be overrepresented in women with dermatomyositis and difficult to detect. A paraneoplastic course, in which the activity of the myositis parallels that of the malignancy, occurs in some patients but is unusual. Although the frequency of malignancy rises with increasing age, young patients may harbor malignancy. The search for malignancy should be directed by symptoms, findings on physical examination, or laboratory testing, and it should be age appropriate.

Entities:  

Mesh:

Year:  1994        PMID: 7865378     DOI: 10.1097/00002281-199411000-00007

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  9 in total

1.  Dermatomyositis associated with celiac disease: response to a gluten-free diet.

Authors:  Min Soo Song; David Farber; Alain Bitton; Jeremy Jass; Michael Singer; George Karpati
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

2.  Dermatomyositis accompanied by rectal cancer: report of a case.

Authors:  K Fujii; Y Moriya; S Fujita; T Akasu; H Miyake; Y Nakanishi; T Saito
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Colon cancer presenting with polymyositis-A case report.

Authors:  O Rominiyi; D M Broman; R Rajaganeshan; C R Selvasekar
Journal:  Int J Surg Case Rep       Date:  2011-07-23

4.  A rare case of docetaxel-induced myositis in a patient with a lung adenocarcinoma.

Authors:  Akane Ishida; Ayumi Ushio; Masao Hashimoto; Satoru Ishii; Go Naka; Motoyasu Iikura; Shinyu Izumi; Masayuki Hojo; Haruhito Sugiyama
Journal:  Thorac Cancer       Date:  2022-05-20       Impact factor: 3.223

5.  Clear cell ovarian carcinoma following polymyositis diagnosis: a case report and review of the literature.

Authors:  I Kalogiannidis; A Papanikolaou; I Xanthakis; A Makedos; N Prapas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

Review 6.  Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology.

Authors:  V Madan; H Chinoy; C E M Griffiths; R G Cooper
Journal:  Clin Exp Dermatol       Date:  2009-07       Impact factor: 3.470

Review 7.  Dermatomyositis after interferon alpha treatment.

Authors:  L L Dietrich; A J Bridges; M R Albertini
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.738

8.  Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.

Authors:  Yao-Fan Fang; Yeong-Jian Jan Wu; Chang-Fu Kuo; Shue-Fen Luo; Kuang-Hui Yu
Journal:  Clin Rheumatol       Date:  2016-05-23       Impact factor: 3.650

9.  A Case of Docetaxel Induced Myositis and Review of the Literature.

Authors:  Alexandra Perel-Winkler; Regina Belokovskaya; Isabelle Amigues; Melissa Larusso; Nazia Hussain
Journal:  Case Rep Rheumatol       Date:  2015-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.